Company Filing History:
Years Active: 2025
Title: Innovations by Jorge Eduardo Vialard
Introduction
Jorge Eduardo Vialard is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of agents that target HPK1 inhibitors. With a total of 2 patents, his work is crucial in the fight against diseases such as cancer.
Latest Patents
Vialard's latest patents include innovative pharmaceutical agents that serve as HPK1 inhibitors. The first patent focuses on compounds that are useful for therapy and/or prophylaxis in mammals, specifically targeting cancer treatment. The second patent, titled "Bicyclic HPK1 inhibitors," also relates to pharmaceutical agents that can be utilized in similar therapeutic contexts.
Career Highlights
Jorge Eduardo Vialard is currently employed at Janssen Pharmaceutica NV, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for patients suffering from serious illnesses.
Collaborations
Some of his notable coworkers include Laurence Anne Mevellec and Sophie Coupa, who contribute to the collaborative environment that fosters innovation at Janssen Pharmaceutica NV.
Conclusion
Jorge Eduardo Vialard's contributions to pharmaceutical innovation, particularly in the area of HPK1 inhibitors, highlight his role as a key figure in the fight against cancer. His patents reflect a dedication to improving health outcomes through scientific advancement.